APVO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aptevo Therapeutics Inc (APVO) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available. The stock shows a declining price trend, lacks positive trading signals, and has poor financial performance. Additionally, there are no positive catalysts or significant insider/hedge fund activity to support a buy decision.
The stock is in a declining trend with a regular market change of -4.01% and post-market change of -0.46%. The RSI is neutral at 34.935, and the MACD is positively contracting but still above 0. Moving averages are converging, and the stock is near its support level (S1: 6.424). There is a 70% chance of further decline (-5.02% in the next week, -12.69% in the next month).
NULL. No recent news or significant trading trends from insiders or hedge funds. No recent congress trading data.
and a significant drop in EPS (-99.38% YoY). The stock is projected to decline further in the short term.
In Q3 2025, revenue was $0 with no growth YoY. Net income improved slightly but remains negative at -$9,028,000. EPS dropped significantly to -40.13 (-99.38% YoY). Gross margin remains at 0%. Overall, the financials are weak and do not support a buy decision.
No data available on analyst ratings or price target changes.
